Eur Rev Med Pharmacol Sci 2021; 25 (6): 2460-2460

DOI: 10.26355/eurrev_202103_25398

LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway

Y. Lei, Y.-H. Wang, X.-F. Wang, J. Bai

Department of Medical Oncology, Shaanxi Provincial People’s Hospital, Xi’An, China.


The article “LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway, by Y. Lei, Y.-H. Wang, X.-F. Wang, J. Bai, published in Eur Rev Med Pharmacol Sci 2018; 22 (19): 6315-6323–DOI: 10.26355/eurrev_201810_16042–PMID: 30338799” has been withdrawn from the authors due to inaccuracies and mistakes throughout the paper.

The Publisher apologizes for any inconvenience this may cause.

LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway

Free PDF Download

To cite this article

Y. Lei, Y.-H. Wang, X.-F. Wang, J. Bai
LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 6
Pages: 2460-2460
DOI: 10.26355/eurrev_202103_25398